Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
Clinical trial NCT05577754 · RECRUITING
Trial details
- NCT number
- NCT05577754
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2027-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.